Jump Financial LLC grew its position in CorVel Co. (NASDAQ:CRVL - Free Report) by 219.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,987 shares of the business services provider's stock after purchasing an additional 6,858 shares during the quarter. Jump Financial LLC's holdings in CorVel were worth $1,111,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Bessemer Group Inc. lifted its position in shares of CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider's stock worth $29,000 after buying an additional 254 shares during the last quarter. Fifth Third Bancorp raised its stake in CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider's stock worth $36,000 after acquiring an additional 101 shares in the last quarter. Jones Financial Companies Lllp purchased a new stake in CorVel in the fourth quarter valued at $37,000. US Bancorp DE boosted its stake in CorVel by 225.4% in the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider's stock valued at $43,000 after acquiring an additional 266 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of CorVel by 175.2% during the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider's stock worth $48,000 after purchasing an additional 275 shares during the last quarter. 51.36% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, StockNews.com raised CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.
View Our Latest Analysis on CRVL
Insider Activity at CorVel
In other news, Director Steven J. Hamerslag sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the transaction, the director now owns 314,000 shares of the company's stock, valued at approximately $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Brandon O'brien sold 1,523 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total value of $182,089.88. Following the sale, the chief financial officer now owns 17,142 shares of the company's stock, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,723 shares of company stock worth $5,757,140 in the last quarter. Company insiders own 47.57% of the company's stock.
CorVel Price Performance
Shares of CRVL stock traded down $0.86 during trading hours on Friday, hitting $110.31. The stock had a trading volume of 185,999 shares, compared to its average volume of 117,314. The firm has a market capitalization of $5.67 billion, a PE ratio of 64.89 and a beta of 0.94. The stock's 50 day moving average is $110.59 and its 200 day moving average is $115.55. CorVel Co. has a twelve month low of $76.53 and a twelve month high of $128.61.
CorVel (NASDAQ:CRVL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.
About CorVel
(
Free Report)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
See Also

Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.